AKT1 and breast carcinoma: Formononetin induced the apoptosis and suppressed phosphorylation of AKT in the cervical cancer HeLa cell line and inhibited cell proliferation in human ovarian and breast cancers by suppressing the PI3K/AKT and ERK1/2 pathways [14,15].